QAIALDO Trademark

Trademark Overview


On Thursday, November 21, 2024, a trademark application was filed for QAIALDO with the United States Patent and Trademark Office. The USPTO has given the QAIALDO trademark a serial number of 79417410. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 20, 2025. This trademark is owned by Nova Laboratories Ltd. The QAIALDO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations, namely oral liquids; pharmaceutical preparations, namely oral suspensions; pharmaceutical preparations for the treatment of heart failure; pharmaceutical preparations for treating or alleviating the symptoms of heart failure; pharmaceutical preparations for use in the management of refractory oedema; pharmaceutical preparations for use in the management of refractory oedema associated with congestive heart failure, hepatic cirrhosis, malignant ascites, nephrotic syndrome or essential hypertension; pharmaceutical preparations for oral delivery; oral liquids used for the treatment of heart failure and for other indications.

Apparatus and devices for the delivery of pharmaceutical preparations; apparatus and devices for the oral delivery of pharmaceutical preparations; oral syringes.
qaialdo

General Information


Serial Number79417410
Word MarkQAIALDO
Filing DateThursday, November 21, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, February 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely oral liquids; pharmaceutical preparations, namely oral suspensions; pharmaceutical preparations for the treatment of heart failure; pharmaceutical preparations for treating or alleviating the symptoms of heart failure; pharmaceutical preparations for use in the management of refractory oedema; pharmaceutical preparations for use in the management of refractory oedema associated with congestive heart failure, hepatic cirrhosis, malignant ascites, nephrotic syndrome or essential hypertension; pharmaceutical preparations for oral delivery; oral liquids used for the treatment of heart failure and for other indications.
Goods and ServicesApparatus and devices for the delivery of pharmaceutical preparations; apparatus and devices for the oral delivery of pharmaceutical preparations; oral syringes.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 20, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNova Laboratories Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, February 20, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 24, 2025APPLICATION FILING RECEIPT MAILED